A detailed history of Riverwater Partners LLC transactions in Pfizer Inc stock. As of the latest transaction made, Riverwater Partners LLC holds 10,141 shares of PFE stock, worth $267,316. This represents 0.16% of its overall portfolio holdings.

Number of Shares
10,141
Previous 10,302 1.56%
Holding current value
$267,316
Previous $288,000 1.74%
% of portfolio
0.16%
Previous 0.24%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$27.7 - $31.39 $4,459 - $5,053
-161 Reduced 1.56%
10,141 $293,000
Q2 2024

Jul 19, 2024

SELL
$25.26 - $29.6 $3,031 - $3,552
-120 Reduced 1.15%
10,302 $288,000
Q1 2024

Apr 18, 2024

SELL
$25.89 - $29.73 $5,152 - $5,916
-199 Reduced 1.87%
10,422 $289,000
Q4 2023

Jan 04, 2024

SELL
$26.13 - $33.94 $42,957 - $55,797
-1,644 Reduced 13.4%
10,621 $305,000
Q3 2023

Oct 18, 2023

BUY
$32.09 - $37.51 $12,386 - $14,478
386 Added 3.25%
12,265 $406,000
Q2 2023

Jul 18, 2023

BUY
$36.12 - $41.79 $830 - $961
23 Added 0.19%
11,879 $435,000
Q1 2023

Apr 12, 2023

SELL
$39.39 - $51.28 $30,645 - $39,895
-778 Reduced 6.16%
11,856 $483,000
Q4 2022

Jan 12, 2023

SELL
$41.75 - $54.5 $11,439 - $14,933
-274 Reduced 2.12%
12,634 $0
Q3 2022

Nov 08, 2022

BUY
$43.76 - $53.42 $3,982 - $4,861
91 Added 0.71%
12,908 $565,000
Q2 2022

Aug 05, 2022

BUY
$46.53 - $55.17 $2,047 - $2,427
44 Added 0.34%
12,817 $672,000
Q1 2022

May 02, 2022

BUY
$45.75 - $56.69 $9,058 - $11,224
198 Added 1.57%
12,773 $661,000
Q4 2021

Jan 31, 2022

BUY
$41.32 - $61.25 $519,599 - $770,218
12,575 New
12,575 $743,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Riverwater Partners LLC Portfolio

Follow Riverwater Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverwater Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverwater Partners LLC with notifications on news.